In resected tumour tissues from patients receiving NAT, MAFs were significantly higher in the ypT1 group than the ypT0 group (average MAFs 3.5 ± 2.62% and 1.1 ± 0.2%, respectively, p = 0.04; Fig. 3B), as expected. This evidence concerns the gene RAB1A and neoplasm.